Importing drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines.
Paul W. Abramowitz
Advertisement
Paul W. Abramowitz, PharmD, ScD (Hon), FASHP, is the CEO of the American Society of Health-System Pharmacists.
Articles by Paul W. Abramowitz
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts
2
The Bottlenecks That Slow Manufacturer Response to Increased Demand for Production
3
Roundup: Rona Therapeutics Enters Global License Agreement for ALK7-targeting RNAi Therapy, Enodia Therapeutics Enters Collaboration and License Agreement to Develop Sec61-Targeting Small Molecules
4
The Manufacturing Issues That Continue to Contribute to Drug Shortages
5